Kestra Private Wealth Services, LLC Halozyme Therapeutics, Inc. Transaction History
Kestra Private Wealth Services, LLC
- $5.67 Billion
- Q4 2024
A detailed history of Kestra Private Wealth Services, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 9,314 shares of HALO stock, worth $528,755. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,314
Previous 18,475
49.59%
Holding current value
$528,755
Previous $1.06 Million
57.86%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
534Shares Held
123MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$732 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$377 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$231 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$193 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.91B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...